在衰老和神经退行性疾病中的糖化
Acta biochimica et biophysica Sinica
|September 3, 2024
概括
蛋白质糖化随着年龄的增长而变化,并影响诸如阿尔茨海默氏症和帕金森氏症等神经退行性疾病. 了解这些变化可能有助于早期发现和治疗疾病.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 老年学是一门学科.
背景情况:
- 老龄化是一个自然过程,涉及生理衰退和增加疾病风险.
- 神经退行性疾病带来了重大的社会和经济挑战.
- 蛋白质糖化是影响蛋白质功能的关键翻译后修饰.
研究的目的:
- 审查蛋白质糖化,衰老和神经退行性疾病之间的联系.
- 探索糖化在阿尔茨海默氏症和帕金森病的病理生理学中的作用.
- 评估糖基化样本作为与年龄相关的神经疾病的潜在生物标志物.
主要方法:
- 关于糖化,衰老和神经退行等研究的文献综述.
- 分析老化过程中糖化模式的变化.
- 检查糖化对蛋白质功能和生物相互作用的影响.
主要成果:
- 葡萄糖化模式随着年龄的增长而发生显著变化.
- 改变的糖基化与神经退行性疾病的发病和进展有关.
- 葡萄糖酶化机制对于蛋白质调节和疾病调解至关重要.
结论:
- 糖化在衰老和神经退行性疾病的发展中起着关键作用.
- 葡萄糖化概况为早期诊断和监测提供了潜在的生物标志物.
- 进一步研究糖基化可以提高对衰老和相关神经系统疾病的理解.
更多相关视频
08:52Measurement of Protein Turnover Rates in Senescent and Non-Dividing Cultured Cells with Metabolic Labeling and Mass Spectrometry
Published on: April 6, 2022
3.5K
08:33Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models
Published on: March 24, 2019
7.5K
相关概念视频
Protein Glycosylation
6.8K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
6.8K
Proteoglycans
3.9K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
Oligosaccharide Assembly
2.8K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
2.8K
Aging
40
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
40
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K
Alzheimer's Disease: Overview
454
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
454
